INVA
Price:
$22.74
Market Cap:
$1.68B
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates w...[Read more]
Industry
Biotechnology
IPO Date
2004-10-05
Stock Exchange
NASDAQ
Ticker
INVA
According to Innoviva, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.41B. This represents a change of 10.49% compared to the average of 1.27B of the last 4 quarters.
The mean historical Enterprise Value of Innoviva, Inc. over the last ten years is 1.52B. The current 1.41B Enterprise Value has changed 9.14% with respect to the historical average. Over the past ten years (40 quarters), INVA's Enterprise Value was at its highest in in the March 2018 quarter at 2.13B. The Enterprise Value was at its lowest in in the September 2020 quarter at 963.35M.
Average
1.52B
Median
1.46B
Minimum
1.07B
Maximum
2.08B
Discovering the peaks and valleys of Innoviva, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.38%
Maximum Annual Enterprise Value = 2.08B
Minimum Annual Increase = -26.91%
Minimum Annual Enterprise Value = 1.07B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.07B | -13.70% |
| 2024 | 1.23B | -5.42% |
| 2023 | 1.31B | 11.00% |
| 2022 | 1.18B | -26.91% |
| 2021 | 1.61B | 15.38% |
| 2020 | 1.39B | -8.94% |
| 2019 | 1.53B | -26.39% |
| 2018 | 2.08B | 1.79% |
| 2017 | 2.04B | 14.93% |
| 2016 | 1.78B | -0.66% |
The current Enterprise Value of Innoviva, Inc. (INVA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
1.20B
5-year avg
1.28B
10-year avg
1.52B
Innoviva, Inc.’s Enterprise Value is greater than MiMedx Group, Inc. (377.93M), greater than Nektar Therapeutics (1.17B), greater than Atai Beckley Inc. (1.40B), less than Syndax Pharmaceuticals, Inc. (1.83B), greater than Inhibrx Biosciences, Inc. (1.20B), greater than Immatics N.V. (797.20M), greater than CureVac N.V. (523.06M), less than Enliven Therapeutics, Inc. (2.68B), less than Relay Therapeutics, Inc. (2.42B), less than Dianthus Therapeutics, Inc. (2.80B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 377.93M | $536.20M | |
| 1.17B | $1.16B | |
| 1.40B | $1.44B | |
| 1.83B | $1.62B | |
| 1.20B | $1.35B | |
| 797.20M | $1.26B | |
| 523.06M | $1.05B | |
| 2.68B | $2.81B | |
| 2.42B | $2.59B | |
| 2.80B | $3.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innoviva, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Innoviva, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Innoviva, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Innoviva, Inc. (INVA)?
What is the 3-year average Enterprise Value for Innoviva, Inc. (INVA)?
What is the 5-year average Enterprise Value for Innoviva, Inc. (INVA)?
How does the current Enterprise Value for Innoviva, Inc. (INVA) compare to its historical average?